Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PLETHICO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PLETHICO PHARMA SANOFI INDIA/
PLETHICO PHARMA
 
P/E (TTM) x 31.0 -0.1 - View Chart
P/BV x 15.4 0.0 91,919.6% View Chart
Dividend Yield % 7.0 0.0 -  

Financials

 SANOFI INDIA   PLETHICO PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
PLETHICO PHARMA
Mar-14
SANOFI INDIA/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs7,939254 3,125.6%   
Low Rs5,45431 17,453.1%   
Sales per share (Unadj.) Rs1,202.8604.6 199.0%  
Earnings per share (Unadj.) Rs269.532.5 829.5%  
Cash flow per share (Unadj.) Rs287.751.3 560.3%  
Dividends per share (Unadj.) Rs570.000-  
Avg Dividend yield %8.50-  
Book value per share (Unadj.) Rs527.0473.7 111.2%  
Shares outstanding (eoy) m23.0334.07 67.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.60.2 2,360.2%   
Avg P/E ratio x24.94.4 566.1%  
P/CF ratio (eoy) x23.32.8 838.0%  
Price / Book Value ratio x12.70.3 4,221.0%  
Dividend payout %211.50-   
Avg Mkt Cap Rs m154,2244,859 3,174.2%   
No. of employees `000NANA-   
Total wages/salary Rs m4,0591,547 262.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,70120,598 134.5%  
Other income Rs m730419 174.0%   
Total revenues Rs m28,43121,017 135.3%   
Gross profit Rs m8,3492,938 284.2%  
Depreciation Rs m419642 65.2%   
Interest Rs m171,747 1.0%   
Profit before tax Rs m8,643968 892.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,437-138 -1,761.0%   
Profit after tax Rs m6,2061,107 560.7%  
Gross profit margin %30.114.3 211.3%  
Effective tax rate %28.2-14.3 -197.3%   
Net profit margin %22.45.4 416.9%  
BALANCE SHEET DATA
Current assets Rs m36,12118,877 191.4%   
Current liabilities Rs m27,42511,896 230.5%   
Net working cap to sales %31.433.9 92.6%  
Current ratio x1.31.6 83.0%  
Inventory Days Days11778 149.4%  
Debtors Days Days17198 8.6%  
Net fixed assets Rs m12,14814,269 85.1%   
Share capital Rs m230341 67.5%   
"Free" reserves Rs m11,90615,798 75.4%   
Net worth Rs m12,13616,139 75.2%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m48,27933,146 145.7%  
Interest coverage x509.41.6 32,770.4%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.6 92.3%   
Return on assets %12.98.6 149.7%  
Return on equity %51.16.9 745.6%  
Return on capital %71.413.0 547.8%  
Exports to sales %14.121.4 65.9%   
Imports to sales %14.615.2 95.7%   
Exports (fob) Rs m3,9044,402 88.7%   
Imports (cif) Rs m4,0373,136 128.7%   
Fx inflow Rs m3,9044,402 88.7%   
Fx outflow Rs m4,0373,184 126.8%   
Net fx Rs m-1331,219 -10.9%   
CASH FLOW
From Operations Rs m3,9872,437 163.6%  
From Investments Rs m6,509-6,265 -103.9%  
From Financial Activity Rs m-15,8272,490 -635.6%  
Net Cashflow Rs m-5,33124 -21,777.0%  

Share Holding

Indian Promoters % 0.0 57.8 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 28.8 19.4 148.5%  
FIIs % 6.3 2.7 233.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 42.3 93.7%  
Shareholders   62,870 16,430 382.7%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs PLETHICO PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs PLETHICO PHARMA Share Price Performance

Period Sanofi India PLETHICO PHARMA S&P BSE HEALTHCARE
1-Day 2.06% -4.91% 1.18%
1-Month -8.09% -1.24% -0.75%
1-Year 44.45% -70.21% 61.82%
3-Year CAGR 0.97% -66.86% 18.16%
5-Year CAGR 7.07% -51.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the PLETHICO PHARMA share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of PLETHICO PHARMA.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of PLETHICO PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.